San Francisco, January 10, 2027 – As the global biopharmaceutical industry gathers in San Francisco for JPM Week, The 8th ACCESS ASIA BD Forum @ JPM 2027 will bring together Asian biotech innovators, global pharmaceutical companies, investors, and business development leaders to explore cross-border partnering opportunities.
View more →
"里程碑达成率仅约22%——条款重心正移向首付与reversion。"10月13日下午，雅法资本主办的10月陆家嘴BD沙龙上，环球律师事务所上海分所合伙人黄旭春给出的这组数据，让在场不少BD负责人陷入沉思。当天，黄旭春律师与法国H.A.C. Pharma战略与业务发展负责人François Huguet先后登台，分别从交易结构与欧洲市场准入两个维度，拆解中国创新药出海的现实路径；雅法资本还现场演示了自研AI决策工具BD Go，多家 biotech 带来路演，数十位买方、卖方及投资机构代表到场交流。
View more →
BIO-Europe 2026 | An Evening Reception in Cologne, Germany Hosted by YAFO Capital and ACCESS ASIA As BIO-Europe approaches, YAFO Capital and ACCESS ASIA will host the ACCESS ASIA Networking Reception @ BIO-Europe 2026 in Cologne, Germany, bringing together professionals across pharma, biotech, and investment who are engaged in Asia–global partnerships.
View more →
Hosted by IPLS & CHBD About Bridge 2026 The Sino-Europe Biopharma BD Partnership Webinar brings together biopharma leaders, investors, business development professionals, and industry experts from China and Europe.
View more →
9 月 23 日下午，在雅法资本主办的 9 月场 BD 沙龙上，天元律所合伙人顾龙围绕生物医药 BD 的交易模式与合规要点，系统拆解了从早期分子许可到成熟期商业化合作的法律框架，也为当下火热的跨境 License in 交易泼了一盆“冷静水”。
View more →
跨境融通，共创共生。为搭建生物医药领域高效对接、深度互通的产业交流平台，雅法陆家嘴 BD 沙龙 8 月专场于 8 月 27 日圆满举办。
View more →
盛夏逐光，创新共生。为搭建生物医药领域高效对接、深度互通的产业交流平台，雅法资本夏季陆家嘴 BD 沙龙近日在雅法资本陆家嘴新办公室圆满举办。
View more →
As BIO Convention approaches, ACCESS ASIA and YAFO Capital will host the ACCESS ASIA Networking Reception @ BIO 2026 in San Diego, bringing together professionals across pharma, biotech, and investment who are engaged in Asia–global partnerships.
View more →
About ACCESS ASIA Spring BD Salon & Reception 2026 The ACCESS ASIA Spring BD Salon & Reception 2026 brings together a select group of biotechnology founders, pharmaceutical business development executives, and investors for focused discussions and relationship building.
View more →
2026 年 4 月 27 日，药通亚洲春季 BD 沙龙暨酒会在上海雅法办公室顺利举办。本次活动延续审核制邀请形式，汇聚了来自跨国药企、创新生物科技公司、投资机构及专业服务机构的行业同仁，在轻松高效的氛围中展开了深入交流。
View more →
San Francisco, January 11, 2026 — The ACCESS ASIA BD Forum @ JPM 2026 was successfully held during JPM Week at the InterContinental San Francisco, serving as a global partnering and business development platform with a strong focus on China and Asia-originated biotech innovation. Organized by ACCESS ASIA and YAFO Capital, with the support of co-organizers CHB, Haomai Tech, and GB-Partner, the forum connected leading Chinese and Asian biotech companies with global pharmaceutical partners, investors, and BD leaders to accelerate cross-border collaboration and licensing opportunities.
View more →The ACCESS ASIA BD Forum @ JPM is one of the most anticipated partnering events during JPM Week, connecting Asia’s most innovative biotech companies with global pharma, investors, and BD leaders. Now in its sixth consecutive year, the Forum builds upon the success of ACCESS CHINA, which has become a key platform for cross-border collaboration and investment discussions.
View more →
On September 25, 2025, the ACCESS Asia Partnering Forum successfully launched its first online showcase: ACCESS Asia Partnering Forum (YAFO) – 100 Innovators to Watch. ACCESS Asia serves as a bridge between the region’s most promising biotech companies and international pharma, investors, and strategic partners. Through digital showcases, live roadshows, and dedicated partnering events at JPM Week and the BIO International Convention, ACCESS Asia brings Asia’s fastest-growing biotech pipelines onto the global stage.
View more →
We are inviting you to be part of the ACCESS ASIA Partnering Forum — a six-month campaign spotlighting 100 biotech innovators from China, Korea, and Japan. The program connects startups with global investors, pharma executives, and strategic partners, culminating in J.P. Morgan Healthcare Week 2026 in San Francisco.
View more →
On June 15th, the ACCESS CHINA BD Forum @ BIO, proudly hosted by YAFO Capital and supported by Ideals, concluded successfully in Boston. The forum brought together over 100 distinguished professionals representing pharmaceutical companies, biotech firms, and venture capital institutions from across the globe. With an agenda that included keynote speeches, in-depth panel discussions, targeted elevator pitches, and a dynamic networking dinner, the event served as a premier platform for knowledge exchange and partnership exploration. Attendees actively engaged in discussions on emerging global trends in pharma and biotech, shared strategic insights, and explored new avenues for collaboration and innovation.
View more →
We are honored to invite you to the ACCESS CHINA BD Forum @BIO, taking place on the afternoon of June 15, 2025, at the Seaport Boston Hotel—just a three-minute walk from the Boston Convention & Exhibition Center.
View more →
We are honored to invite you to join our “ACCESS CHINA Biotech Forum” online and in San Francisco in January 2025. During the 3-week event, we will host Online Showcases for international and China biotech companies for presentations, a Dinner Reception to gather senior management from both international and China pharma for networking, and 1x1 meetings with Yafo clients for partnering opportunities.
View more →
We are honored to invite you to join our “ACCESS CHINA Partnering Forum – Autumn Virtual Showcase” on Sep 24 – 25 (live), and 27 (VoD) 2024. ACCESS CHINA Partnering Forum helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, the audience can have access to innovative pharma and healthcare products from worldwide. We look forward to welcoming you to our Autumn event in October!
View more →
We are delighted to invite you to our upcoming ACCESS CHINA BD Networking Event before ChinaBio. This event will be held on September 9th, from 4:30 PM to 7:30 PM at 3F, 1305-1 South Suzhou Road, Shanghai (near Suzhou River).
View more →
We are honored to invite you to join our “ACCESS CHINA Partnering Forum (Spring) in May 2024. During this event, we will host Virtual Roadshows for international and China biotech companies for presentations. Conference Name: ACCESS CHINA Partnering Forum (Spring) Date & Venue: May 14th, 2024 Online Scale: Expected 500 participants online; 50 company roadshows Participants: Pharma/Biotech senior management and BDs. ACCESS CHINA has been held every quarter since 2020 and has served as a China cross-border corporate access platform, helping biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. Bringing together international and China Biotech BDs and CEOs, ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing, or commercial collaborations. We look forward to meeting you online!
View more →
We are honored to invite you to join our “ACCESS CHINA Partnering Forum” during JPM week in January, 2024. During this event, we will host Online Showcases for international and China biotech companies for presentations, Dinner Reception to gather senior management from both international and China pharma for networking, and 1×1 meetings to YAFO clients for partnering opportunity.
View more →
We are honored to invite you to join our “ACCESS CHINA Partnering Forum” on Oct. 16th-17th, 2023. ACCESS CHINA Autumn Showcase will help biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online.
View more →
We cordially invite you to attend the ‘ACCESS CHINA – Boston Forum @BIO’ scheduled to be held on June 4th and June 13th-14th, 2023, in Boston and online, respectively. This event is expected to be the largest China-themed gathering during the BIO Convention 2023. The main theme of the forum is “Building Effective Partnerships in Asia: Strategies for Collaboration and Growth”.
View more →
We have invited executives from renowned pharmaceutical companies and biotech firms, as well as industry professionals, to share their experiences and insights, and provide valuable advice and guidance for China’s innovative drugs out-licensing.
View more →
The Largest China Pharma Partnering and Networking Event During JPM 2023, SF & Online
View more →
We cordially invite you to join our “ACCESS CHINA Biotech Forum Spring Showcase 2022” to be held online from April 18th to 19th, 2022. ACCESS CHINA forum expects to have over 1000 participants from China pharma and Biotech companies.
View more →
We cordially invite you to join our “ACCESS CHINA Biotech Forum Spring Showcase 2022” to be held online from April 18th to 19th, 2022. ACCESS CHINA forum expects to have over 1000 participants from China pharma and Biotech companies.
View more →
We cordially invite you to join our “ACCESS CHINA Biotech Forum @JPM Week 2022” to be held online from January 4th to 14th, 2022. As the largest CHINA corporate access event during the JPM WEEK in 2022, the forum expects to have over 1000 participants from China pharma and Biotech companies.
View more →
The largest China oriented healthcare partnering event – “ACCESS CHINA Biotech Forum @ The 16th China Pharma & MedTech BD Forum” was held in Suzhou and online on September 23rd-30th, 2021.
View more →
The largest China oriented healthcare partnering event – We are honored to invite you to our “ACCESS CHINA Biotech Forum @ Bio Convention Week 2021”，which will take place on June 9th-18th, 2021. This conference is the largest China oriented corporate access event with 100+ company presentations, 10 keynote speeches, and 500+ participants during Bio Convention Week.
View more →
Hundreds of biopharma executives congregated for ACCESS CHINA to meet with the potential partners for development, licensing or commercial collaborations. The two-day conference agenda included company presentations and panel discussion.
View more →
(Shanghai, December 21, 2020) Shanghai YAFO Life Science and BioToChina.org are organizing ACCESS CHINA Forum 2021 to be held between January 4th and 22nd. As the largest China corporate access event during the JPM Conference weeks, ACCESS CHINA 2021 expects to host more than 30 keynote speakers and 100 company presentations from North America, Europe, China and Rest of Asia. We expect more than 1000 participants from China and the global biopharma industry and investment community. Over 90 global biopharma companies have confirmed presenting. 40+ presenters from China include Fosun, Tasly, Shanghai Pharma, Grand Pharma and 7 MNCs like Abbott, Bayer, MSD, BD, SERVIER, and etc.
View more →
[October 10th, 2020 Qingdao] YAFO Life Science, along with our partners, has successfully organized ACCESS CHINA Autumn Event on September 25th at Shangri-La Hotel in Qingdao. We helped over 50 overseas companies to present about 140 assets in front of hundreds of big pharmaceutical companies in China.
View more →
YAFO Life Science, along with our partners, has successfully organized the largest online corporate access event between China and Western biopharma industry on July 31st. We helped 29 overseas companies from 8 countries covering America, Asia, Europe, and China efficiently present their assets online in front of hundreds of big pharmaceutical companies in China.
View more →
YAFO Capital is organizing 2020 ACCESS CHINA BD Forum at BIO International Convention 2020 on June 7, 2020 at the Omni Hotels & Resorts in San Diego. ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders to China, by directly meeting the right people for licensing and/or commercial partners. Our VIRTUAL ACCESS CHINA program offers forum participants opportunity to expand the exposure to much broader Chinese audiences.
View more →
COVID-19 has a profound impact on global economy, and the healthcare industry has received high attention from the whole society. YAFO Life Science along with our partners has successfully organized the largest online corporate access event between China and Western biopharma industry on May 15th and 22nd. We helped 35 overseas companies from 10 countries covering America, Asia, Europe, and China efficiently present their assets online in front of hundreds of big pharmaceutical companies in China.
View more →
Following the YAFO JPM Mixing Dinner 2019, YAFO Capital together with Renexes and CHBD will provide an exciting Pre-JPM networking event that combining ski and fireside chat this year. The Mixing Dinner in San Francisco will include 50 to 100 people this year from China, Japan and US. The Pre-JPM Ski Tahoe and the Bio Fireside Chat event will be held at a ski resort in Lake Tahoe.
View more →
NASH (non-alcoholic steatohepatitis) is a huge unmet clinical need, and behind it is a new drug opportunity that cannot be missed.
View more →
In 2010, recognizing that the healthcare reform and industry growth was spurring a new wave of emerging Chinese healthcare companies, a group of investors led the efforts to organize China Healthcare Investment Conference (CHIC). This prestigious event has since grown into the most powerful platform to promote and nurture the Chinese healthcare investment ecosystem and further develop the industry.
View more →
San Francisco, January 10, 2027 – As the global biopharmaceutical industry gathers in San Francisco for JPM Week, The 8th ACCESS ASIA BD Forum @ JPM 2027 will bring together Asian biotech innovators, global pharmaceutical companies, investors, and business development leaders to explore cross-border partnering opportunities.
View more →"里程碑达成率仅约22%——条款重心正移向首付与reversion。"10月13日下午，雅法资本主办的10月陆家嘴BD沙龙上，环球律师事务所上海分所合伙人黄旭春给出的这组数据，让在场不少BD负责人陷入沉思。当天，黄旭春律师与法国H.A.C. Pharma战略与业务发展负责人François Huguet先后登台，分别从交易结构与欧洲市场准入两个维度，拆解中国创新药出海的现实路径；雅法资本还现场演示了自研AI决策工具BD Go，多家 biotech 带来路演，数十位买方、卖方及投资机构代表到场交流。
View more →BIO-Europe 2026 | An Evening Reception in Cologne, Germany Hosted by YAFO Capital and ACCESS ASIA As BIO-Europe approaches, YAFO Capital and ACCESS ASIA will host the ACCESS ASIA Networking Reception @ BIO-Europe 2026 in Cologne, Germany, bringing together professionals across pharma, biotech, and investment who are engaged in Asia–global partnerships.
View more →Hosted by IPLS & CHBD About Bridge 2026 The Sino-Europe Biopharma BD Partnership Webinar brings together biopharma leaders, investors, business development professionals, and industry experts from China and Europe.
View more →9 月 23 日下午，在雅法资本主办的 9 月场 BD 沙龙上，天元律所合伙人顾龙围绕生物医药 BD 的交易模式与合规要点，系统拆解了从早期分子许可到成熟期商业化合作的法律框架，也为当下火热的跨境 License in 交易泼了一盆“冷静水”。
View more →跨境融通，共创共生。为搭建生物医药领域高效对接、深度互通的产业交流平台，雅法陆家嘴 BD 沙龙 8 月专场于 8 月 27 日圆满举办。
View more →盛夏逐光，创新共生。为搭建生物医药领域高效对接、深度互通的产业交流平台，雅法资本夏季陆家嘴 BD 沙龙近日在雅法资本陆家嘴新办公室圆满举办。
View more →As BIO Convention approaches, ACCESS ASIA and YAFO Capital will host the ACCESS ASIA Networking Reception @ BIO 2026 in San Diego, bringing together professionals across pharma, biotech, and investment who are engaged in Asia–global partnerships.
View more →About ACCESS ASIA Spring BD Salon & Reception 2026 The ACCESS ASIA Spring BD Salon & Reception 2026 brings together a select group of biotechnology founders, pharmaceutical business development executives, and investors for focused discussions and relationship building.
View more →2026 年 4 月 27 日，药通亚洲春季 BD 沙龙暨酒会在上海雅法办公室顺利举办。本次活动延续审核制邀请形式，汇聚了来自跨国药企、创新生物科技公司、投资机构及专业服务机构的行业同仁，在轻松高效的氛围中展开了深入交流。
View more →San Francisco, January 11, 2026 — The ACCESS ASIA BD Forum @ JPM 2026 was successfully held during JPM Week at the InterContinental San Francisco, serving as a global partnering and business development platform with a strong focus on China and Asia-originated biotech innovation. Organized by ACCESS ASIA and YAFO Capital, with the support of co-organizers CHB, Haomai Tech, and GB-Partner, the forum connected leading Chinese and Asian biotech companies with global pharmaceutical partners, investors, and BD leaders to accelerate cross-border collaboration and licensing opportunities.
View more →The ACCESS ASIA BD Forum @ JPM is one of the most anticipated partnering events during JPM Week, connecting Asia’s most innovative biotech companies with global pharma, investors, and BD leaders. Now in its sixth consecutive year, the Forum builds upon the success of ACCESS CHINA, which has become a key platform for cross-border collaboration and investment discussions.
View more →On September 25, 2025, the ACCESS Asia Partnering Forum successfully launched its first online showcase: ACCESS Asia Partnering Forum (YAFO) – 100 Innovators to Watch. ACCESS Asia serves as a bridge between the region’s most promising biotech companies and international pharma, investors, and strategic partners. Through digital showcases, live roadshows, and dedicated partnering events at JPM Week and the BIO International Convention, ACCESS Asia brings Asia’s fastest-growing biotech pipelines onto the global stage.
View more →We are inviting you to be part of the ACCESS ASIA Partnering Forum — a six-month campaign spotlighting 100 biotech innovators from China, Korea, and Japan. The program connects startups with global investors, pharma executives, and strategic partners, culminating in J.P. Morgan Healthcare Week 2026 in San Francisco.
View more →On June 15th, the ACCESS CHINA BD Forum @ BIO, proudly hosted by YAFO Capital and supported by Ideals, concluded successfully in Boston. The forum brought together over 100 distinguished professionals representing pharmaceutical companies, biotech firms, and venture capital institutions from across the globe. With an agenda that included keynote speeches, in-depth panel discussions, targeted elevator pitches, and a dynamic networking dinner, the event served as a premier platform for knowledge exchange and partnership exploration. Attendees actively engaged in discussions on emerging global trends in pharma and biotech, shared strategic insights, and explored new avenues for collaboration and innovation.
View more →We are honored to invite you to the ACCESS CHINA BD Forum @BIO, taking place on the afternoon of June 15, 2025, at the Seaport Boston Hotel—just a three-minute walk from the Boston Convention & Exhibition Center.
View more →We are honored to invite you to join our “ACCESS CHINA Biotech Forum” online and in San Francisco in January 2025. During the 3-week event, we will host Online Showcases for international and China biotech companies for presentations, a Dinner Reception to gather senior management from both international and China pharma for networking, and 1x1 meetings with Yafo clients for partnering opportunities.
View more →We are honored to invite you to join our “ACCESS CHINA Partnering Forum – Autumn Virtual Showcase” on Sep 24 – 25 (live), and 27 (VoD) 2024. ACCESS CHINA Partnering Forum helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, the audience can have access to innovative pharma and healthcare products from worldwide. We look forward to welcoming you to our Autumn event in October!
View more →We are delighted to invite you to our upcoming ACCESS CHINA BD Networking Event before ChinaBio. This event will be held on September 9th, from 4:30 PM to 7:30 PM at 3F, 1305-1 South Suzhou Road, Shanghai (near Suzhou River).
View more →We are honored to invite you to join our “ACCESS CHINA Partnering Forum (Spring) in May 2024. During this event, we will host Virtual Roadshows for international and China biotech companies for presentations. Conference Name: ACCESS CHINA Partnering Forum (Spring) Date & Venue: May 14th, 2024 Online Scale: Expected 500 participants online; 50 company roadshows Participants: Pharma/Biotech senior management and BDs. ACCESS CHINA has been held every quarter since 2020 and has served as a China cross-border corporate access platform, helping biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. Bringing together international and China Biotech BDs and CEOs, ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing, or commercial collaborations. We look forward to meeting you online!
View more →We are honored to invite you to join our “ACCESS CHINA Partnering Forum” during JPM week in January, 2024. During this event, we will host Online Showcases for international and China biotech companies for presentations, Dinner Reception to gather senior management from both international and China pharma for networking, and 1×1 meetings to YAFO clients for partnering opportunity.
View more →We are honored to invite you to join our “ACCESS CHINA Partnering Forum” on Oct. 16th-17th, 2023. ACCESS CHINA Autumn Showcase will help biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online.
View more →We cordially invite you to attend the ‘ACCESS CHINA – Boston Forum @BIO’ scheduled to be held on June 4th and June 13th-14th, 2023, in Boston and online, respectively. This event is expected to be the largest China-themed gathering during the BIO Convention 2023. The main theme of the forum is “Building Effective Partnerships in Asia: Strategies for Collaboration and Growth”.
View more →We have invited executives from renowned pharmaceutical companies and biotech firms, as well as industry professionals, to share their experiences and insights, and provide valuable advice and guidance for China’s innovative drugs out-licensing.
View more →The Largest China Pharma Partnering and Networking Event During JPM 2023, SF & Online
View more →We cordially invite you to join our “ACCESS CHINA Biotech Forum Spring Showcase 2022” to be held online from April 18th to 19th, 2022. ACCESS CHINA forum expects to have over 1000 participants from China pharma and Biotech companies.
View more →We cordially invite you to join our “ACCESS CHINA Biotech Forum Spring Showcase 2022” to be held online from April 18th to 19th, 2022. ACCESS CHINA forum expects to have over 1000 participants from China pharma and Biotech companies.
View more →We cordially invite you to join our “ACCESS CHINA Biotech Forum @JPM Week 2022” to be held online from January 4th to 14th, 2022. As the largest CHINA corporate access event during the JPM WEEK in 2022, the forum expects to have over 1000 participants from China pharma and Biotech companies.
View more →The largest China oriented healthcare partnering event – “ACCESS CHINA Biotech Forum @ The 16th China Pharma & MedTech BD Forum” was held in Suzhou and online on September 23rd-30th, 2021.
View more →The largest China oriented healthcare partnering event – We are honored to invite you to our “ACCESS CHINA Biotech Forum @ Bio Convention Week 2021”，which will take place on June 9th-18th, 2021. This conference is the largest China oriented corporate access event with 100+ company presentations, 10 keynote speeches, and 500+ participants during Bio Convention Week.
View more →Hundreds of biopharma executives congregated for ACCESS CHINA to meet with the potential partners for development, licensing or commercial collaborations. The two-day conference agenda included company presentations and panel discussion.
View more →(Shanghai, December 21, 2020) Shanghai YAFO Life Science and BioToChina.org are organizing ACCESS CHINA Forum 2021 to be held between January 4th and 22nd. As the largest China corporate access event during the JPM Conference weeks, ACCESS CHINA 2021 expects to host more than 30 keynote speakers and 100 company presentations from North America, Europe, China and Rest of Asia. We expect more than 1000 participants from China and the global biopharma industry and investment community. Over 90 global biopharma companies have confirmed presenting. 40+ presenters from China include Fosun, Tasly, Shanghai Pharma, Grand Pharma and 7 MNCs like Abbott, Bayer, MSD, BD, SERVIER, and etc.
View more →[October 10th, 2020 Qingdao] YAFO Life Science, along with our partners, has successfully organized ACCESS CHINA Autumn Event on September 25th at Shangri-La Hotel in Qingdao. We helped over 50 overseas companies to present about 140 assets in front of hundreds of big pharmaceutical companies in China.
View more →YAFO Life Science, along with our partners, has successfully organized the largest online corporate access event between China and Western biopharma industry on July 31st. We helped 29 overseas companies from 8 countries covering America, Asia, Europe, and China efficiently present their assets online in front of hundreds of big pharmaceutical companies in China.
View more →YAFO Capital is organizing 2020 ACCESS CHINA BD Forum at BIO International Convention 2020 on June 7, 2020 at the Omni Hotels & Resorts in San Diego. ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders to China, by directly meeting the right people for licensing and/or commercial partners. Our VIRTUAL ACCESS CHINA program offers forum participants opportunity to expand the exposure to much broader Chinese audiences.
View more →COVID-19 has a profound impact on global economy, and the healthcare industry has received high attention from the whole society. YAFO Life Science along with our partners has successfully organized the largest online corporate access event between China and Western biopharma industry on May 15th and 22nd. We helped 35 overseas companies from 10 countries covering America, Asia, Europe, and China efficiently present their assets online in front of hundreds of big pharmaceutical companies in China.
View more →Following the YAFO JPM Mixing Dinner 2019, YAFO Capital together with Renexes and CHBD will provide an exciting Pre-JPM networking event that combining ski and fireside chat this year. The Mixing Dinner in San Francisco will include 50 to 100 people this year from China, Japan and US. The Pre-JPM Ski Tahoe and the Bio Fireside Chat event will be held at a ski resort in Lake Tahoe.
View more →NASH (non-alcoholic steatohepatitis) is a huge unmet clinical need, and behind it is a new drug opportunity that cannot be missed.
View more →In 2010, recognizing that the healthcare reform and industry growth was spurring a new wave of emerging Chinese healthcare companies, a group of investors led the efforts to organize China Healthcare Investment Conference (CHIC). This prestigious event has since grown into the most powerful platform to promote and nurture the Chinese healthcare investment ecosystem and further develop the industry.
View more →